Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 6/20 | 0.39 |
| ▸ | ACHE | P22303 | 5/20 | 0.34 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | BCHE | P06276 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23805895 | 0.92 | PDK2 (0.42) | PDK2 | |
| SCHEMBL23805931 | 0.87 | PDK2 (0.39) | PDK2ACHECNR2ALDH1A1BCHE | |
| SCHEMBL22745272 | 0.85 | PDK2 (0.43) | PDK2ACHEBCHE | |
| SCHEMBL23805884 | 0.83 | PDK2 (0.39) | PDK2ALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL22745257 | 0.80 | PDK2 (0.39) | PDK2ACHECNR2ALDH1A1BCHE | |
| SCHEMBL23805893 | 0.79 | PDK2 (0.43) | PDK2 | |
| SCHEMBL23805864 | 0.78 | PDK2 (0.38) | PDK2 | |
| SCHEMBL23805928 | 0.78 | ALDH1A1 (0.39) | PDK2ACHECNR2ALDH1A1BCHE | |
| SCHEMBL23805868 | 0.76 | PDK2 (0.38) | PDK2 | |
| SCHEMBL4650526 | 0.75 | RIPK1 (0.43) | SMN1; SMN2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11118065-B2 | Fluorenylaminoketone photoinitiator, preparation method thereof, and UV photocurable composition containing same | CHANGZHOU TRONLY ADVANCED ELECTRONIC MATERIALS CO., LTD. (CN) | 2021-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11118065-B2 | Fluorenylaminoketone photoinitiator, preparation method thereof, and UV photocurable composition containing same | TRPA1, TYR, PKLR | PDK2 58/4885ACHE 1228/4885CNR2 3275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.